Dynamics of SARS-CoV-2 lineages in French Guiana in 2020-2021: 4 epidemic waves with cross-influences from Europe and South America
- PMID: 36184049
- PMCID: PMC9529336
- DOI: 10.1016/j.meegid.2022.105370
Dynamics of SARS-CoV-2 lineages in French Guiana in 2020-2021: 4 epidemic waves with cross-influences from Europe and South America
Abstract
Since the first cases of SARS-CoV-2 infection in Wuhan in December 2019, this RNA virus gave rise to different viral lineages with different virological, epidemiological and immunological properties. Here we describe the dynamics of circulation of SARS-CoV-2 lineages in an Amazonian South American French overseas territory, French Guiana (FG). The data analyzed are based on the general epidemic course, and genomic surveillance data come from whole genome sequencing (WGS) as well as typing PCRs. From March 2020 to October 2021, four COVID-19 epidemic waves were observed in FG with an evolution of viral lineages influenced by virus introductions from continental France and above all by land-based introductions from neighbouring countries. The third epidemic wave from March to June 2021 was driven by a predominant Gamma introduced from Brazil and a less frequent Alpha introduced from France. This coexistence was completely substituted by Delta that initiated the fourth epidemic wave.
Keywords: Dynamics of circulation; French Guiana; Genomic surveillance; SARS-CoV2 variants; Variant of concern.
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Figures
References
-
- Andronico A., Tran Kiem C., Paireau J., Succo T., Bosetti P., Lefrancq N., Nacher M., Djossou F., Sanna A., Flamand C., et al. Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana. Nat. Commun. 2021;12:1634. doi: 10.1038/s41467-021-21944-4. - DOI - PMC - PubMed
-
- Barros-Martins J., Hammerschmidt S.I., Cossmann A., Odak I., Stankov M.V., Morillas Ramos G., Dopfer-Jablonka A., Heidemann A., Ritter C., Friedrichsen M., et al. Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 NCoV-19/BNT162b2 vaccination. Nat. Med. 2021;1–5 doi: 10.1038/s41591-021-01449-9. - DOI - PMC - PubMed
-
- Buss L.F., Prete C.A., Abrahim C.M.M., Mendrone A., Salomon T., de Almeida-Neto C., França R.F.O., Belotti M.C., Carvalho M.P.S.S., Costa A.G., et al. Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science. 2021;371:288–292. doi: 10.1126/science.abe9728. - DOI - PMC - PubMed
-
- Cherian S., Potdar V., Jadhav S., Yadav P., Gupta N., Das M., Rakshit P., Singh S., Abraham P., Panda S., et al. SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra. India. Microorganisms. 2021;9:1542. doi: 10.3390/microorganisms9071542. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
